GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cencora Inc (NYSE:COR) » Definitions » Cyclically Adjusted Price-to-FCF

COR (Cencora) Cyclically Adjusted Price-to-FCF : 23.62 (As of Jun. 01, 2025)


View and export this data going back to 1995. Start your Free Trial

What is Cencora Cyclically Adjusted Price-to-FCF?

As of today (2025-06-01), Cencora's current share price is $291.24. Cencora's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was $12.33. Cencora's Cyclically Adjusted Price-to-FCF for today is 23.62.

The historical rank and industry rank for Cencora's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

COR' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 10.56   Med: 15.26   Max: 30.05
Current: 23.62

During the past years, Cencora's highest Cyclically Adjusted Price-to-FCF was 30.05. The lowest was 10.56. And the median was 15.26.

COR's Cyclically Adjusted Price-to-FCF is ranked worse than
52.27% of 44 companies
in the Medical Distribution industry
Industry Median: 22.205 vs COR: 23.62

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Cencora's adjusted free cash flow per share data for the three months ended in Mar. 2025 was $16.516. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $12.33 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Cencora Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Cencora's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cencora Cyclically Adjusted Price-to-FCF Chart

Cencora Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.46 13.52 13.48 15.27 17.44

Cencora Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.43 17.49 17.44 20.50 22.55

Competitive Comparison of Cencora's Cyclically Adjusted Price-to-FCF

For the Medical Distribution subindustry, Cencora's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cencora's Cyclically Adjusted Price-to-FCF Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Cencora's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Cencora's Cyclically Adjusted Price-to-FCF falls into.


;
;

Cencora Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Cencora's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=291.24/12.33
=23.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cencora's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Cencora's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=16.516/134.9266*134.9266
=16.516

Current CPI (Mar. 2025) = 134.9266.

Cencora Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 4.453 100.684 5.967
201509 5.128 100.392 6.892
201512 2.918 99.792 3.945
201603 3.506 100.470 4.708
201606 0.275 101.688 0.365
201609 5.289 101.861 7.006
201612 -2.557 101.863 -3.387
201703 3.044 102.862 3.993
201706 -1.593 103.349 -2.080
201709 5.808 104.136 7.525
201712 -0.287 104.011 -0.372
201803 -0.822 105.290 -1.053
201806 3.369 106.317 4.276
201809 2.655 106.507 3.363
201812 1.868 105.998 2.378
201903 2.550 107.251 3.208
201906 2.361 108.070 2.948
201909 2.774 108.329 3.455
201912 0.364 108.420 0.453
202003 3.747 108.902 4.642
202006 -0.947 108.767 -1.175
202009 5.785 109.815 7.108
202012 4.050 109.897 4.972
202103 -2.605 111.754 -3.145
202106 5.198 114.631 6.118
202109 4.008 115.734 4.673
202112 3.711 117.630 4.257
202203 0.646 121.301 0.719
202206 1.394 125.017 1.504
202209 4.720 125.227 5.086
202212 3.075 125.222 3.313
202303 2.578 127.348 2.731
202306 3.135 128.729 3.286
202309 8.119 129.860 8.436
202312 4.018 129.419 4.189
202403 -4.927 131.776 -5.045
202406 11.796 132.554 12.007
202409 4.130 133.029 4.189
202412 -14.472 133.157 -14.664
202503 16.516 134.927 16.516

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cencora  (NYSE:COR) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Cencora Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Cencora's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Cencora Business Description

Industry
Address
1 West First Avenue, Conshohocken, PA, USA, 19428-1800
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Executives
Steven H Collis officer: President & CEO 1300 MORRIS DRIVE, SUITE 100, CHESTERBROOK PA 19087
Robert P. Mauch officer: Executive Vice President 1300 MORRIS DRIVE, CHESTERBROOK PA 19087
Lon R Greenberg director 460 NORTH GULPH ROAD, KING OF PRUSSIA PA 19406
Elizabeth S Campbell officer: Executive Vice President 1 WEST FIRST AVENUE, CONSHOHOCKEN PA 19428
Lazarus Krikorian officer: Senior Vice President 1300 MORRIS DRIVE, CHESTERBROOK PA 19087
Silvana Battaglia officer: Executive Vice President 227 WASHINGTON STREET, CONSHOHOCKEN PA 19428
Walgreens Boots Alliance, Inc. 10 percent owner 108 WILMOT ROAD, DEERFIELD IL 60015
Gina Clark officer: Executive Vice President 1300 MORRIS DRIVE, CHESTERBROOK PA 19087
Dermot Mark Durcan director
Leslie E Donato officer: EVP & Chief Strategy Officer 227 WASHINGTON STREET, CONSHOHOCKEN PA 19428
Werner Baumann director 1 WEST FIRST AVENUE, CONSHOHOCKEN PA 19428
Lauren M Tyler director C/O ALLEGHANY CORPORATION, 1411 BROADWAY, 34TH FLOOR, NEW YORK NY 10018
Redonda Miller director 303 WYMAN STREET, SUITE 300, WALTHAM MA 02451
Lorence H. Kim director C/O SERES HEALTH, INC., 161 FIRST STREET, CAMBRIDGE MA 02472
Walgreens Boots Alliance Holdings Llc 10 percent owner 108 WILMOT ROAD, DEERFIELD IL 60015